Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranirestat in diabetic sensorimotor polyneuropathy
NCT00101426Phase 3Completed
- Sponsor
- Sumitomo Pharma
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ranirestat in diabetic sensorimotor polyneuropathy (DSPN), sponsored by Sumitomo Pharma. Started Oct 2004; status: completed.
02
Drugs
ranirestat
03
Conditions
diabetic sensorimotor polyneuropathy (DSPN)
Beyond the preview
Go deeper on NCT00101426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101426.